Larimar Therapeutics, Inc. (LRMR) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $2.92M2014: $13.08M2015: $20.00M2016: $9.89M2017: $27.29M2018: $28.49M2019: $5.89M2020: $14.99M2021: $14.25M2022: $15.50M2023: $14.21M2024: $28.41M2025: $67.76M$67.76M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$67.76M+138.5%
2024$28.41M+99.9%
2023$14.21M-8.3%
2022$15.50M+8.8%
2021$14.25M-4.9%
2020$14.99M+154.4%
2019$5.89M-79.3%
2018$28.49M+4.4%
2017$27.29M+175.9%
2016$9.89M-50.5%
2015$20.00M+52.9%
2014$13.08M+348.6%
2013$2.92M